Logo of National Eczema Association mobile menu icon
Icon link to National Eczema's Instagram feed. Icon link to National Eczema's YouTube channel. Icon link to National Eczema's Facebook page. Icon link to National Eczema's Twitter feed. Icon link to National Eczema's inspire.com page. Search Icon to search the site

Get the tools and support you need to best manage your eczema

  • This field is for validation purposes and should be left unchanged.

Eczema Matters

Browsing Articles Tagged with the Topic ofDupixent

Dupixent may soon be approved for teenagers

Dupixent may soon be approved for teenagers

Dupixent, a biologic drug for moderate to severe AD, may soon be available to patients aged 12 to 18 if the treatment co...

Itching for relief from my eczema

Itching for relief from my eczema

A diplomat and certified yoga teacher traveled the world looking for effective treatments for her atopic dermatitis unti...

Take charge of your eczema!

Take charge of your eczema!

Getting your atopic dermatitis symptoms under control will be much easier if you take it step by step. ...

A Second Biologic Drug for Atopic Dermatitis Makes Its Way to Market

A Second Biologic Drug for Atopic Dermatitis Makes Its Way to Market

Following on the heels of Dupixent (dupilumab)—the first-ever biologic drug for atopic dermatitis (the most common typ...

NEA Celebrates Another Win for Access to New Atopic Dermatitis Therapy Dupixent

NEA Celebrates Another Win for Access to New Atopic Dermatitis Therapy Dupixent

ICER, a nonprofit that conducts independent reviews on clinical effectiveness and value of treatments, found Dupixent t...

Never Lose Hope

Never Lose Hope

A newly approved treatment finally brings relief to a woman who's coped with severe eczema for more than 70 years....

Q & A: Introducing Biologics with Dr. Paul Yamauchi

Q & A: Introducing Biologics with Dr. Paul Yamauchi

In March, the FDA approved Dupixent, the first biologic medication for adults with moderate to severe atopic dermatitis....

First Biologic Approved for Moderate to Severe Atopic Dermatitis

First Biologic Approved for Moderate to Severe Atopic Dermatitis

The U.S. Food and Drug Administration approved Dupixent (dupilumab), the first biologic medication for adults with moder...

Another Step Closer

Another Step Closer

June 9, 2016 - On Monday, June 6, 2016 the pharmaceutical companies Regeneron and Sanofi, reported posi...